Bourgeon Capital Management LLC Acquires 2,480 Shares of Becton, Dickinson and Company (BDX)

Bourgeon Capital Management LLC increased its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 8.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,387 shares of the medical instruments supplier’s stock after acquiring an additional 2,480 shares during the period. Becton, Dickinson and comprises approximately 3.7% of Bourgeon Capital Management LLC’s holdings, making the stock its 4th largest holding. Bourgeon Capital Management LLC’s holdings in Becton, Dickinson and were worth $5,929,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. grew its position in Becton, Dickinson and by 2,427.8% during the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock worth $3,034,470,000 after acquiring an additional 15,887,611 shares during the last quarter. Vanguard Group Inc. grew its position in Becton, Dickinson and by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock worth $2,917,094,000 after acquiring an additional 796,034 shares during the last quarter. JPMorgan Chase & Co. grew its position in Becton, Dickinson and by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock worth $727,863,000 after acquiring an additional 242,081 shares during the last quarter. Wells Fargo & Company MN grew its position in Becton, Dickinson and by 1.2% during the 1st quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock worth $602,246,000 after acquiring an additional 39,362 shares during the last quarter. Finally, Fundsmith LLP grew its position in Becton, Dickinson and by 3.2% during the 1st quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock worth $421,291,000 after acquiring an additional 71,691 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

Becton, Dickinson and Company (BDX) opened at 202.20 on Wednesday. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63. The stock has a 50 day moving average price of $200.08 and a 200-day moving average price of $191.02. The firm has a market cap of $46.01 billion, a P/E ratio of 58.56 and a beta of 1.06.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The company’s revenue was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.35 earnings per share. Equities research analysts forecast that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.73 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.44%. Becton, Dickinson and’s payout ratio is presently 83.43%.

COPYRIGHT VIOLATION WARNING: “Bourgeon Capital Management LLC Acquires 2,480 Shares of Becton, Dickinson and Company (BDX)” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/09/13/bourgeon-capital-management-llc-acquires-2480-shares-of-becton-dickinson-and-company-bdx.html.

A number of equities research analysts recently commented on BDX shares. BidaskClub lowered Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Piper Jaffray Companies restated a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a research report on Tuesday. Bank of America Corporation restated a “buy” rating and set a $225.00 price target (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. Becton, Dickinson and currently has a consensus rating of “Buy” and an average price target of $196.93.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the sale, the insider now owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gary M. Cohen sold 15,044 shares of the business’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $200.43, for a total transaction of $3,015,268.92. Following the sale, the insider now directly owns 95,270 shares in the company, valued at approximately $19,094,966.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 75,904 shares of company stock worth $15,242,688. Insiders own 1.40% of the company’s stock.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply